Use of IFN-γ and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases-Reference-Cited by-同舟云学术

Use of IFN-γ and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases

Published:2017-10 Issue:4 Volume:75 Page:315-325
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Villar-Hernández Raquel,Latorre Irene,Mínguez Sonia,Díaz Jéssica,García-García Esther,Muriel-Moreno Beatriz,Lacoma Alicia,Prat Cristina,Olivé Alex,Ruhwald Morten,Mateo Lourdes,Domínguez José

Funder

Instituto de Salud Carlos III

ISCIII-Subdirección General de Evaluación

Fondo Europeo de Desarrollo Regional (FEDER)

CERCA Programme/Generalitat de Catalunya

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference63 articles.

1. Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis;Cantini;Semin Arthr Rheum,2017

2. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent;Keane;N Engl J Med,2001

3. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management;Gardam;Lancet Infect Dis,2003

4. Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice;Cantini;Autoimmun Rev,2015

5. The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement;Solovic;Eur Respir J,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alternative biomarkers of tuberculosis infection in patients with immune-mediated inflammatory diseases;Frontiers in Medicine;2023-11-23

2. Performance of T-Track® TB, a Novel Dual Marker RT-qPCR-Based Whole-Blood Test for Improved Detection of Active Tuberculosis;Diagnostics;2023-02-16

3. Complete blood count in the elderly vs. selected biochemical parameters associated with inflammation. Results of PolSenior2 study;Diagnostyka Laboratoryjna;2022-08-23

4. Advances in diagnostic tools for respiratory tract infections: from tuberculosis to COVID-19 – changing paradigms?;ERJ Open Research;2022-06-23

5. Interferon-Inducible Protein-10 as a Marker to Detect Latent Tuberculosis Infection in Patients with Inflammatory Rheumatic Diseases;Journal of Personalized Medicine;2022-06-23